Subscribe To
SPPI / ROSEN, A LEADING LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors With Losses to Secure Counsel Before Important November 1 Deadline in Securities Class Action - SPPI
SPPI News
By Seeking Alpha
June 22, 2023
Spectrum's Rolvedon A Differentiator In A $3B/Yr Market
Spectrum and Assertio's merger would lead to a diversified product portfolio and a combination of two unique marketing strategies. Spectrum's ROLVEDON more_horizontal
By Zacks Investment Research
May 9, 2023
Spectrum Pharmaceuticals (SPPI) Reports Q1 Loss, Tops Revenue Estimates
Spectrum Pharmaceuticals (SPPI) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compare more_horizontal
By InvestorPlace
April 25, 2023
Why Is Spectrum Pharmaceuticals (SPPI) Stock Up 35% Today?
Spectrum Pharmaceuticals (NASDAQ: SPPI ) stock is soaring higher on Tuesday thanks to an acquisition deal with Assertio (NASDAQ: ASRT ). This deal w more_horizontal
By Seeking Alpha
March 22, 2023
Spectrum Pharmaceuticals, Inc. (SPPI) Q4 2022 Earnings Call Transcript
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI ) Q4 2022 Earnings Conference Call March 22, 2023 8:30 AM ET Company Participants Thomas Riga - President more_horizontal
By Business Wire
March 17, 2023
Spectrum Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update
BOSTON--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies more_horizontal
By Zacks Investment Research
November 28, 2022
Spectrum's (SPPI) NDA for NSCLC Candidate Gets CRL From FDA
Spectrum (SPPI) gets a CRL from the FDA for poziotinib as the agency requires additional data. The company de-prioritized the poziotinib program. more_horizontal
By PennyStocks
September 9, 2022
Penny Stocks To Buy: The Good, Bad, & Ugly & 3 To Watch Now
Whether you're a seasoned trader making money with penny stocks or just more_horizontal
By Seeking Alpha
August 11, 2022
Spectrum Pharmaceuticals, Inc. (SPPI) CEO Thomas Riga on Q2 2022 Results - Earnings Call Transcript
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI ) Q2 2022 Earnings Conference Call August 11, 2022 8:30 AM ET Company Participants Michael Grabow - SVP, C more_horizontal